美股連升兩日,標普500指數史上首次收在5,500點以上,納斯達克指數突破18,000點到數市,雙雙創新高。聯邦儲備局主席鮑威爾表示,對抗通脹的行動「取得相當大的進展」,惟未有暗示減息路線圖;Tesla上季電動車出貨量好過預期,股價急漲一成。
(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his push for cheaper medicines by demanding price cuts on their blockbuster weight-loss and diabetes drugs. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineeUS Allies Allege China Is Developing Attack Drones for RussiaPowerful Storm Beryl Aims at Jamaica After Grenada StrikeS&P 500 Closes Above 5,500 in Record-Breaking Run: Markets WrapBiden Plummets
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.